Effectiveness of Exercise-Based Cardiac Rehabilitation for Heart Transplant Recipients: A Systematic Review and Meta-Analysis

Data de publicação:

Autores da FMUP

  • Emilia Da Conceição Torres Dias Moreira

    Autor

  • José Carlos De Magalhães Silva Cardoso

    Autor

  • Luís Filipe Ribeiro De Azevedo

    Autor

  • Roberto Rodrigues Pinto

    Autor

Participantes de fora da FMUP

  • Costa, R
  • Ribeiro, JA

Unidades de investigação

Abstract

Background:Heart Transplant (HTx) is the ultimate chance of life for end stage Heart Failure (HF). Exercise training has consistently shown the potential to improve functional capacity in various chronic heart diseases. Still, the evidence in HTx recipients is scarcer. This study aims to systematically review the literature to evaluate the effectiveness and safety of Exercise-based Cardiac Rehabilitation (EBCR) in HTx recipients and to identify possible moderators of success. Methods:We conducted a systematic review and meta-analysis of randomized controlled trials on the effect and safety of EBCR in adult HTx recipients. The primary outcome was functional capacity, measured by Peak Oxygen Uptake (pVO2). We searched CENTRAL, MEDLINE, Embase, Scopus, and Web of Knowledge databases until December 2020, reviewed references of relevant articles and contacted experts. Usual care (UC), the different dosages of exercise regimens and alternative settings were allowed as comparators. A quantitative synthesis of evidence was performed using random-effects meta-analyses. Results:A total of 11 studies with 404 patients were included. Nine studies comprising 306 patients compared EBCR with usual care. They showed that EBCR improved pVO2 compared to usual care (Mean Difference [MD] 3.03 mL/kg/min, 95% CI [2.28-3.77]; I-2 = 32%). In the subgroup analysis, including length of intervention and timing of enrollment after HTx, no significant moderator was found. Two trials, with 98 patients total, compared High Intensity Interval Training (HIIT) and Moderate Intensity Continuous Training (MICT). HIIT attained a significant edge over MICT (MD 2.23 mL/kg/min, 95% CI [1.79-2.67]; I-2 = 0%). No major adverse events associated with EBCR were reported. Conclusion:We found moderate quality evidence suggesting EBCR has a significant benefit on functional capacity improvement HTx recipients at the short-term. HIIT showed superiority when compared to MICT. Research focusing long term outcomes and standardized protocols are needed to improve evidence on EBCR effectiveness.

Dados da publicação

ISSN/ISSNe:
1178-6329, 1178-6329

Health Services Insights  SAGE Publications Ltd

Tipo:
Review
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 11

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Heart transplant; rehabilitation; high intensity interval training; systematic review; meta-analysis

Financiamento

Proyectos asociados

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS) - NCT05021835

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (ZEUS) . Novo Nordisk . 2022

Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects on Cardiovascular Risk Markers, in Healthy Human Volunteers (FUNCTIONALTUNA) - NCT03742492

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Ensaio Clínico Académico (FUNCTIONALTUNA) . CINTESIS . 2019

Registo global de insuficiência cardíaca congestiva.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Académico (IC_Congestiva) . 2019

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (EMPERIAL) . Boehringer Ingelheim . 2020

Envolva-se com o seu coração: Promoção da adesão terapêutica com um sistema de telemonitorização para pessoas com insuficiência cardíaca crónica. (AdHeart)

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo de Intervenção Académico (AdHeart) . FCT . 2019

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico (Sacubitril/Valsartan) . 2020

Telemedicine in Heart Failure management

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2022

Can Progress Tests Improve Medical Students’ ECG Interpretation Skills? A Feasibility Trial.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Académico (ECG) . 2022

Avaliação da aorta ascendente em doentes operados a tetralogia de Fallot: implicações no follow-up clínico e imagiológico

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Health Tecnology Assessment of Nutrition an Food Productd - The Scientific Evidence Behind Health Claims

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Estudo Clínico Académico . 2020

Comparative effectiveness of opioid therapy for the long term management of chronic non cancer pain

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Estudo Clínico Académico . 2020

Reversão da remodelagem ventricular na miocardiopatia dilatada idiopática

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação